Abstract
It has long been evident that there are substances in blood and tissues which are capable of destroying angiotensin. The effects of temperature, pH changes and dialysis on angiotensin survival in renin assay systems indicated that enzymes were probably involved (Braun-Menendez and Fasciolo, 1939; Page and Helmer, 1940). The generic term “angiotensinase” is used to describe these enzymes, although their specificity is unproven.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ames, R. P., Borkowski, A. J., Sicinski, A. M., Laragh, J. H.: Prolonged infusions of angiotensin II and norepinephrine and blood pressure, electrolyte balance, aldosterone and Cortisol secretion in normal man. J. clin. Invest. 44, 1171–1186 (1965).
Bakhle, Y. S.: Conversion of angiotensin I to angiotensin II by cell free extracts of dog lung. Nature (Lond.) 220, 919–921 (1968).
Bakhle, Y. S., Reynard, A. M., Vane, J. R.: Metabolism of the angiotensins in isolated perfused tissues. Nature (Lond.) 222, 956–959 (1969).
Bailie, M. D., Rector, F. C., Seldin, D. W.: Angiotensin II in arterial and renal venous plasma and renal lymph in the dog. J. clin. Invest. 50, 119–126 (1971).
Bing, J.: Angiotensinase content of kidneys of normal and hypertensive rats. Acta path. microbiol. Scand. 56, 385–387 (1962).
Biron, P., Campeatj, L.: Pulmonary and extra-pulmonary fate of angiotensin I. Rev. canad. Biol. 30, 27–34 (1971).
Biron, P., Campeau, L., David, P.: Fate of angiotensin I and II in the human pulmonary circulation. Amer. J. Cardiol. 24, 544–547 (1969).
Biron, P., Landesman, R., Hunt, J. C.: Plasma angiotensinase activity in human hypertension. Nature (Lond.) 204, 1096 (1964).
Biron, P., Meyer, P.: Hepatic Extraction of angiotensin after carbon tetrachloride intoxication. Rev. canad. Biol. 27, 277–279 (1968).
Biron, P., Meyer, P., Panisset, J. C.: Removal of angiotensins from the systemic circulation. Canad. J. Physiol. Pharmacol. 46, 175–178 (1968).
Blaqtjier, P., Bohr, D. F., Taqtjini, A. C., Hoobler, S. W.: Renin and angiotensinase content of the kidney of normal and hypertensive rats. Proc. Soc. exp. Biol. (N. Y.) 108, 711–715 (1961).
Botjrgoignie, J., Ktjrz, S., Perry, H. M.: Control of vascular reactivity to angiotensin in rats. Absh. Proc. IV. Internat. Congress Nephrol. Stockholm (1969), 196.
Bratjn-Menendez, E., Fasciolo, J. C.: Accion vasocontrictora e hipertensora de la sangre venosa del rinou en isquenianicompleta agnda. Rev. Soc. argent. Biol. 15, 161–172 (1939).
Brunner, H. R., Chang, P., Wallach, R., Sealey, J. E., Laragh, J. H.: Angiotensin II vascular receptors: their avidity in relationship to sodium balance, the autonomic nervous system and hypertension. J. clin. Invest, (in press).
Bumptjs, F. M., Smeby, P. R., Page, I. H., Khairallah, P. A.: Distribution and Metabolic Fate of Angiotensin H and various Derivatives. Canad. med. Ass. J. 90, 190–193 (1964).
Chamberlain, M. S., Browse, N. L., Gibson, D. G., Gleeson, J. A.: Angiotensin and reno-portal Anastomosis. Brit. med. J. 1964 II, 1507–1508.
Croxatto, H., Croxatto, R., Illanes, G., Salvestini, H.: Action de la quimotrepsinia y de la tripsina sobre la Hypertensina y los principios presor y ocitocico de la post hypotisio. Rev. Med. Aliment. (Santiago) 5, 300–302 (1965).
Croxatto, R., Croxatto, H.: Destruction of hypertensin and pepsitensin by an amino- peptidase obtained from yeast. Science 96, 519–520 (1942).
Dengler, H., Reichel, G.: Untersuchungen zur intrazellulären Lokalisation der Renin- und Hypertensinase-Aktivität. Experientia (Basel) 16, 36–38 (1960).
Dexter, L.: The hypertensinase content of plasma of normal, hypertensive and nephrectomised dogs. Ann. intern. Med. 17, 447–450 (1942).
Doyle, A. E., Louis, W. J., Osborn, E. C.: Plasma angiotensinase activity on angiotensin II and analogues. Aust. J. exp. Biol. med. Sci. 45, 41–50 (1967).
Fasciolo, J. C., Leloir, L. F., Muñoz, J. M., Braun-Menedez, E.: La hipertensinasa, su dosaje y distribución. Rev. Soc. argent. Biol. 16, 643–649 (1940).
Gaddum, J. H.: Technique of superfusion. Brit. J. Pharmacol. 8, 321–326 (1953).
Glenner, G. G., McMillan, P. H. J., Folk, L. F.: A mammalian peptidase specific for the hydrolysis of N-terminal L-L glutamyl and aspartyl residues. Nature (Lond.) 194, 867 (1962).
Goffinet, J. A., Mulrow, P. J.: Estimation of angiotensin clearance by an in vivo assay. Clin. Res. 1965 II, 408.
Haynes, F. W., Dexter, L.: Renal humoral pressor mechanism in man III. hypertensinase content of plasma of control subjects, and of patients with hypertension and other diseases. J. clin. Invest. 24, 78–81 (1945).
Haynes, F. W., Dexter, L.: Renin, hypertensinogen, and hypertensinase concentrations of blood of dogs during the development of hypertension by constriction of the renal artery. Amer. J. Physiol. 150, 190–197 (1947).
Hickler, R. B., Lanler, D. P., Thorn, G. W.: Plasma angiotensinase activity in patients with hypertension and oedema. J. clin. Invest. 42, 635–648 (1963).
Hirasawa, K.: Studies on renin — angiotensin system (I) studies on angiotensinase activity in liver disease. Jap. Circulât. J. 32, 355–356, 407–415 (1968).
Hirasawa, K.: Studies on renin — angiotensin system. (II) studies on renal angiotensinase activity. Jap. Circulât. J. 38, 979–980, 985–990 (1969).
Hodge, R. L., Ng, K. K. F., Vane, J. R.: Disappearance of angiotensin from the circulation of the dog. Nature (Lond.) 215, 138–141 (1967).
Itskovitz, H. D., Miller, L. D.: Differential studies of angiotensinase: Activities from several tissue sources. Amer. J. med. Sci. 254, 659–666 (1967).
Itskovitz, H. D., Miller, L., Ural, W., Zapp, J., White, R.: Inactivation of angiotensin in shock. Amer. J. Physiol. 216, 5–10 (1969).
Jelinek, J., Mannel, H., Gross, F.: Inactivation of angiotensin H by rat kidney homo- genates. Arch. Pharmak. 268, 446–457 (1971).
Johnson, D. C.: Bsc Thesis. Univ. of Oxford (1967).
Johnson, D. C., Ryan, J. W.: Degradation of angiotensin II by a carboxypeptidase of rabbit liver. Biochim. biophys. Acta (Amst.) 160, 196–203 (1968).
Johnston, C. I., Mendelsohn, F. A. O., Doyle, A. E.: The metabolism of angiotensin II in sodium depution and hypertension in humans. Circulât. Res. (in press).
Kaplan, N. M., Silah, J. G.: The effects of angiotensin II on the blood pressure of humans with hypertensive disease. J. clin. Invest. 43, 659–669 (1964).
Kitatrallah, P. A., Bumpus, F. M., Page, I. H., Smeby, R. R.: Angiotensinase with a high degree of specificity in plasma and red cells. Science 140, 672–674 (1963).
Khatrallah, P. A., Page, I. H.: Plasma angiotensinases. Biochem. Med. 1, 1–8 (1967).
Klatjs, D.: Untersuchungen über die Angiotensinase in Serum Gesunder und Kranker. Klin. Wschr. 40, 701–702 (1962).
Klaus, D., Kaffarnick, H., Pfeil, H.: Untersuchungen über die Serum-Angiotensinase II. Klinische Ergebnisse beim Hochdruck und bei Lebererkrankungen. Klin. Wschr. 41, 380–385 (1963).
Kokubu, T., Ueda, E., Fujimoto, S., Hiwada, K., Sanga, M., Yamamura, Y.: Plasma Angiotensinase activity in liver disease. Clin. chim. Acta 12, 484–488 (1965).
Kuchel, O., Hornky, K., Pazourek, M., Gregorovua, I.: Pressor hyporeactivity to angiotensin in addisons disease. Lancet 1964 II, 1316–1317.
Lagrue, G., Meyer, P.: Dosage biologique de rangiotensinase plasmatique. Technique et premiers résultats. Path, et Biol. 1968 II, 895–897.
Landesman, R., Biron, P., Castellanos, R., La Russa, R., Wilson, K. H.: Plasma angiotensinase activity in normal and toxaemic pregnancy. Obstet, and Gynec. 22, 316–323 (1963)
Laragh, J. H.: Hormones and the pathogenesis of congestive heart failure: Vasopressor aldosterone, and angiotensin II. Further evidence for renal-adrenal interaction from studies in hypertension and cirrhosis. Circulation 25, 1015–1023 (1962).
Leaky, W. P., Ledingham, J. G.: Pressor response to infusion of angiotensin in the portal vein of the Rat. Nature (Lond.) 220, 180–181 (1968).
Leary, W. P., Ledingham, J. G.: Removal of angiotensin by isolated perfused organs of the Rat. Nature (Lond.) 222, 959–960 (1969).
Leary, W. P., Smith, U.: In-situ perfusion of isolated rat lung. Life Sciences 9, 1321–1326 (1970).
Leary, W. P. P.: Aspects of the renin-angiotensin system D. Phil. Thesis, Univ. of Oxford (1970).
Leary, W. P. P., Ledingham, J. G. G.: (1) Renal and hepatic inactivation of angiotensin in Rats. Influence of sodium balance and renal artery compression. Clin. Sci. 38, 573–582 (1970)
Leary, W. P. P., Ledingham, J. G.: (2) Inactivation of angiotensin II. analogues by isolated perfused rat Liver and kidney. Nature (Lond.) 227, 178–179 (1970).
Lee, M. R.: The estimation of renin in biological fluids. D. Phil. Thesis Univ. of Oxford (1965).
Lentz, K. E., Skeggs, L. T., Woods, K. R., Kahn, J. R., Shumway, N. P.: The aminoacid composition of hypertensin II and its biochemical relationship to angiotensin I. J. exp. Med. 104, 183–191 (1956).
Ltjbash, G. D., Bard, R. H., Kline, J. A.: Serum ‘angiotensinase activity’ and female steroidal hormones. Amer J. med. Sci. 257, 155–163 (1969).
Ltjbash, G. D., Hammel, E. C., Mearles, R. J.: Serum angiotensinase activity in hypertension. Clin. Chim. Acta 18, 439–445 (1967).
Ltjbash, G. D., Hammel, E. C., Mearles, R. J.: Serum angiotensinase activity in cirrhosis. Amer. J. med. Sci. 255, 105–112 (1968).
Ltjbash, G. D., Mtjiesan, G. E., Alicandri, C. L., Garfinkel, D. J., Siekierski, E. C., McConnatjghey, C. K.: Plasma angiotensin, serum angiotensinase activity and blood pressure response during angiotensin II amide infusions in normal volunteers. Experientia (Basel) 27, 68–69 (1971).
Matstjnaga, M.: Nature of lysosomal angiotensinase activity. Jap. Circulat. J. 35, 333–338 (1971)
Matstjnaga, M., Kira, J., Saito, N., Ogino, K., Takayastj, M.: Acid angiotensinase, renin, and acid adenosine triphosphatase in rat kidney lysosomes. Jap. Circulat. J. 32, 137–143 (1968).
Matstjnaga, M., Masson, G. M. C.: Hepatic and renal neutral angiotensinases. Experientia (Basel) 26, 1297–1298 (1970).
Matstjnaga, M., Saito, N., Kira, J., Ogino, K., Takayastj, M.: Acid angiotensinase as a lysosomal enzyme. Jap. Circulat. J. 33, 545–551 (1969).
Methot, A. L., Meyer, P., Biron, P., Lorain, M. F., Lagrtje, G., Mttjjez, P.: Hepatic inactivation of angiotensin. Nature (Lond.) 203, 531–532 (1964).
Nagatstj, I. T., Gillespie, I. L., Folk, J. E., Glenner, G. G.: Serum Aminopeptidase, “Angiotensinase”, and hypertensin I degradation of Angiotensin II by Human Serum. Biochem. Pharmacol. 14, 721–728 (1965).
Nagatstj, I. T, Gillespie, I. L., George, J. M., Folk, J. E., Glenner, G. G.: Serum Amino- peptidase “Angiotensinase” and Hypertension-II. Aminoacid B-Naphthylamide Hydrolysis by Normal and Hypertensive Serum. Biochem. Pharmacol. 14, 853–861 (1965).
Nagatstj, I. T., Yamamoto, T., Glenner, G. G., Mehl, J. W.: Purification of aminopeptidase A in human serum and degradation of angiotensin II by the purified enzyme. Biochim. biophys. Acta (Amst.) 198, 255–270 (1970).
Ng, K. K. F., Vane, J. R.: Fate of angiotensin I in the circulation. Nature (Lond.) 218, 144–150 (1968).
Osborne, M. J., D’Atjriac, G. A., Meyer, P., Worcel, M.: Mechanism of extraction of angiotensin II in coronary and renal circulations. Life Sci. 9, 859–867 (1970).
Osborn, E. C., Hughes, S. G., Purie, A. T., Willicombe, P. R., Mahler, R. F.: Clearance studies of angiotensin II and (35S) phenvlthiocarbanyl-angiotensin II in the sheep and dog. Cardiovasc. Res. 3, 134–146 (1969).
Ostrovsky, D., Gornall, A. G.: Effects of aldosterone and other adrenal hormones on the blood pressure responses to renin and angiotensin. Canad. med. Ass. J. 90, 180–184 (1964).
Page, I. H., Helmer, O. M.: A crystaline pressor substance (angiotonin) resulting from the reaction between renin and reninactivator. J. exp. Med. 71, 29–42 (1940).
Page, I. H., McCubbin, J. W.: Renal Hypertension. Year Book Medical Publishers. Chicago 1968.
Peart, W. S.: A new method of large scale preparation of hypertensin with a role on its assay. Biochem. J. 59, 300–302 (1955).
Pickens, P. T., Bumpus, F. M., Lloyd, A. M., Smeby, R. R., Page, I. H.: Measurement of renin activity in human plasma. Circulat. Res. 17, 438–448 (1965).
Plentl, A. A., Page, I. H.: Enzymatic nature of angiotensin formation from renin and renin activator. J. biol. Chem. 147, 135–141 (1943).
Regoli, D., Riniker, B., Brunner, H. R.: The enzymatic degradation of various angiotensin II derivatives by serum, plasma or kidney homogenates. Biochem. Pharmacol. 12, 637–646 (1963).
Regoli, D., Vane, J. R.: The continuous estimation of angiotensin formed in the circulation of the dog. J. Physiol. (Lond.) 183, 513–531 (1966).
Reid, W. D., Laragh, J. H.: Sodium and potassium intake, blood pressure and pressor response to angiotensin. Proc. Soc. exp. Biol. (N. Y.) 120, 26–29 (1965).
Ryan, J. W., Stewart, J. M., Leary, W. P., Ledingham, J. G.: Metabolism of angiotensin I in the pulmonary circulation. Biochem. J. 120, 221–223 (1970).
Saito, N., Sanada, A. K., Matsunaga, M., Kira, J., Mtjkaino, S., Ogino, K., Takayasu, M.: Amino-acid analysis after degradation of angiotensin II by rat kidney lysosomes. Jap. Circulat. J. 33, 87–93 (1969).
Turker, R. K., Yamamoto, M., Bumpijs, F. M., Khairallah, P. A.: Lung perfusion with angiotensin I and II. Evidence of release of myotropic and inhibition substances. Circulat. Res. 28, 559–567 (1971).
Wernze, H., Ftjjii, J.: Hepatische Inaktivierung und Pressorische Wirkung von Angiotensin. Z. ges. exp. Med. 140, 128–235 (1966).
Wolf, R. L., Mendlowitz, M., Gitlow, S. E., Naftchi, N. E.: Metabolism of angiotensin HI131 in normotensive and hypertensive human subjects. Circulation 23, 754–758 (1961).
Yang, H. Y. T., Erdos, E. G., Chiang, T. S.: New Enzymatic route for the inactivation of angiotensin. Nature (Lond.) 218, 1224–1225 (1968).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1974 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Ledingham, J.G., Leary, W.P. (1974). Catabolism of Angiotensin II. In: Page, I.H., Bumpus, F.M. (eds) Angiotensin. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 37. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-65600-2_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-65600-2_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-65602-6
Online ISBN: 978-3-642-65600-2
eBook Packages: Springer Book Archive